NF‐κB protects from the lysosomal pathway of cell death

By Ni Liu, S. Raja, F. Zazzeroni, S. Metkar, Ramila Shah, Manling Zhang, Yue Wang, D. Brömme, W. Russin, Justine C. Lee and 4 more. EMBO Journal, 2003

103 citations recorded by the source corpus.

The programme of gene expression induced by RelA/NF‐κB transcription factors is critical to the control of cell survival. Ligation of ‘death receptors’ such as tumor necrosis factor receptor 1 (TNF‐R1) triggers apoptosis, as well as NF‐κB, which counteracts this process by activating the transcription of anti‐apoptotic genes. In addition to activating caspases, TNF‐R1 stimulation causes the release of cathepsins, most notably cathepsin B, from the lysosome into the cytoplasm where they induce apoptosis. Here we report a mechanism by which NF‐κB protects cells against TNF‐α‐induced apoptosis: inhibition of the lysosomal pathway of apoptosis. NF‐κB can protect cells from death after TNF‐R1 stimulation, by extinguishing cathepsin B activity in the cytosol. This activity of NF‐κB is mediated, at least in part, by the upregulation of Serine protease inhibitor 2A (Spi2A), a potent inhibitor of cathepsin B. Indeed, Spi2A can substitute for NF‐κB in suppressing the induction of cathepsin B activity in the cytosol. Thus, inhibition of cathepsin B by Spi2A is a mechanism by which NF‐κB protects cells from lysosome‐mediated apoptosis.

Subfields: Cancer Research, Molecular Biology, Parasitology

View Paper: https://www.semanticscholar.org/paper/93a2a2b9d99ebbf9b16ec8902b4c557c00d5c12e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

  1. Guido Kroemer
  2. M. Jäättelä

In Molecular Biology

  1. Guido Kroemer
  2. P. Boya
  3. M. Jäättelä
  4. L. Galluzzi
  5. Douglas R. Green
  6. Beth Levine
  7. Simone Fulda

In Parasitology

  1. Guido Kroemer
  2. M. Jäättelä

Citations in the corpus